Prescription Tracking and Public Health
- Adriane Fugh-Berman M.D.
- … show all 1 hide
Monitoring and modifying physicians’ prescribing behavior through prescription tracking is integral to pharmaceutical marketing. Health information organizations (HIOs) combine prescription information purchased from pharmacies with anonymized patient medical records purchased from health insurance companies to determine which drugs individual physicians prefer for specific diagnoses and patient populations. This information is used to tailor marketing strategies to individual physicians and to assess the effect of promotions on prescribing behavior.
The American Medical Association (AMA) created the Prescription Data Restriction Plan in an attempt to address both the privacy concerns of physicians and industry concerns that legislation could compromise the availability of prescribing data. However, the PDRP only prohibits sales representatives and their immediate supervisors from accessing the most detailed reports. Less than 2% of US physicians have registered for the PDRP, and those who have signed up are not the physicians who are targeted for marketing.
Although it has been argued that prescription tracking benefits public health, data gathered by HIOs is designed for marketing drugs. These data are sequestered by industry and are not generally available for genuine public health purposes.
- Fugh-Berman, A, Ahari, S (2007) Following the script: how drug reps influence prescribing. PLoS Med 4: pp. e150 CrossRef
- Niles, S (2006) No way to fill in the blanks. Med Ad News 25: pp. 1-5
- Rawson K. Flying blind: learning to live without physician prescribing data. RPM Report. 2007 (January). Windhover Information. Available at http://therpmreport.com/. Accessed February 25, 2008.
- Greene, JA (2007) Pharmaceutical marketing research and the prescribing physician. Ann Int Med 146: pp. 742-748
- Alonso J, Menzies D. Just what the doctor ordered. Pharm Exec. 2006; (Successful Sales Management Supplement) 26(5):14–6. May.
- Steinbrook, R (2006) For sale: physicians’ prescribing data. New Engl J Med 354: pp. 2745-2747 CrossRef
- Telephone interview with Robert Mills, Media Relations, AMA. December 8, 2006 and May 29, 2007.
- Medical Marketing Service. Available at http://mmslists.com/main.asp (View lists; Physicians). Accessed March 18, 2007.
- Tsang J-P, Rudychev I. The sample equation. Med Mark Media. 2006;41(2):53–8. February.
- IMS. IMS Annual Report 2006. Available at http://www.imshealth.com/vgn/images/portal/CIT_40000873/44/9/80649404IMS_2006_AR.pdf. Accessed February 25, 2008.
- Nickum C, Brand R. Using integrated data sets to truly differentiate physicians. Product Manag Today. 2005;16(8). September. Available at http://www.PMToday.com.
- American Medical Association. Physician Data Restriction Program (PDRP). Available at http://www.ama-assn.org/ama/pub/category/12054.html#1. Accessed February 25, 2008.
- Herscovits B. Small percentage of physicians enroll in PDRP. Pharm Exec Direct. 2006. (July 19). Available at http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=359195&searchString=PDRP. Accessed February 25, 2008.
- Lee C. Doctors, Legislators Resist Drugmakers’ Prying Eyes. Washington Post 2007 (May 22):A01.
- Iskowitz M. New options arm doctors who say, ‘Don’t use my Rx data.’ Med Mark Media. 2008. January 24. Available at http://www.mmm-online.com/New-options-arm-doctors-who-say-Dont-use-my-Rx-data/article/104483/. Accessed February 24, 2008.
- Tsai AC. Prescriber profiling (letter). Ann Intern Med. 2008;148(1):81. Available at http://www.annals.org/cgi/eletters/146/10/751-15848. Accessed February 25, 2008.
- Musacchio RJ, Hunkler RA. More than a game of keep-away. Pharmaceutical Executive 2006 (May 1). Available at http://www.ama-assn.org/ama1/pub/upload/mm/432/pdrppharexecmay06.pdf. Accessed February 25, 2008.
- IMS Health Incorporated, et. al. v. Kelly Ayotte, as Attorney General of the State of New Hampshire. Case No. 06-cv-280-PB. Opinion No. 2007 DNH 061 P. Available at http://pharmedout.org/news.htm (see decision under Court Strikes Law Barring Sale of Drug Data).
- American Medical Association. PDRP: the choice is yours. Available at http://www.ama-assn.org/ama1/pub/upload/mm/432/pdrp_brochure.pdf. Accessed August 1, 2007.
- Statement of the Pharmaceutical Research and Manufacturers of America (PhRMA) Maryland Senate Bill 266. February 1, 2007. Presented at hearing March 1, 2007.
- Ross, W (2006) The battle of New Hampshire: a state law banning commercial use of prescription audit data is meant to protect physicians’ privacy. Med Mark Media 41: pp. 60-64
- IMS 2006 Annual Report. Available at http://www.imshealth.com/ims/portal/front/articleC/0,2777,6599_8650_81159942,00.html. Accessed April 24, 2008.
- Crystal, S, Akincigil, A, Bilder, S, Walkup, JT (2007) Studying prescription drug use and outcomes with Medicaid claims data: strengths, limitations, and strategies. Med Care 45: pp. S58-S65
- Hennessy, S, Leonard, CE, Palumbo, CM, Newcomb, C, Bilker, WB (2007) Quality of Medicaid and Medicare data obtained through Centers for Medicare and Medicaid Services (CMS). Med Care 45: pp. 1216-1220 CrossRef
- Von Allmen H, Stuchlach W. Traveling through time to more accurately forecast brand performance. Product Manag Today. 2006;17(9):12–3. September.
- Prescription Tracking and Public Health
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Journal of General Internal Medicine
Volume 23, Issue 8 , pp 1277-1280
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- prescription tracking
- public health
- pharmaceutical companies
- health information organizations
- prescribing behavior
- pharmaceutical marketing
- patient-level data
- Industry Sectors
- Author Affiliations
- 1. Department of Physiology and Biophysics, Georgetown University Medical Center, Washington, DC, USA